WOLVERINE ASSET MANAGEMENT LLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,373,729
-20.4%
45,400,0000.0%0.33%
-24.7%
Q2 2023$36,908,513
-1.1%
45,400,000
+19.8%
0.44%
-0.7%
Q1 2023$37,317,810
+8.0%
37,900,0000.0%0.44%
+23.2%
Q4 2022$34,560,605
-10.7%
37,900,0000.0%0.36%
-14.1%
Q3 2022$38,693,000
+3.8%
37,900,000
+2.4%
0.42%
+11.8%
Q2 2022$37,277,000
+2.8%
37,000,000
+8.8%
0.37%
+5.4%
Q1 2022$36,271,00034,000,0000.35%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 45,000,000$474,089,0009.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,000,000$4,280,0000.96%
DeepCurrents Investment Group LLC 22,150,000$23,650,0000.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 19,000,000$19,967,0000.46%
Context Capital Management, LLC 5,750$6,138,0000.40%
WOLVERINE ASSET MANAGEMENT LLC 34,000,000$36,271,0000.35%
Polar Asset Management Partners Inc. 15,000,000$15,993,0000.17%
LINDEN ADVISORS LP 20,000,000$21,281,0000.13%
Wellesley Asset Management 1,599$1,599,0000.11%
Verition Fund Management LLC 6,213,000$6,614,0000.08%
View complete list of TRAVERE THERAPEUTICS INC shareholders